logo

For the Inventor, By the Inventor

London, United Kingdom

The Institute of Cancer Research: Royal Cancer Hospital


USPTO Granted Patents = 51



Trademarks = 1

Forward Citations = 174

Loading Chart...
Loading Chart...

214 inventors (with patents filed for the assignee):

goldMedal Dan Niculescu-Duvaz (11 out of 26 patents)

silverMedal Caroline Joy Springer (11 out of 41 patents)

bronzeMedal Robert George Boyle (9 out of 23 patents)

4.  Richard Marais (9 out of 26 patents)

5.  Ian James Collins (9 out of 41 patents)

6.  Valerio Berdini (7 out of 43 patents)

7.  Paul Graham Wyatt (7 out of 24 patents)

8.  David Winter Walker (6 out of 17 patents)

9.  Deborah Smithen (6 out of 6 patents)

10.  Leo Leung (6 out of 6 patents)

11.  Gordon Saxty (6 out of 41 patents)

12.  Steven Woodhead (6 out of 7 patents)

13.  Haoran Tang (5 out of 5 patents)

14.  Udai Banerji (4 out of 4 patents)

15.  Alfonso Zambon (4 out of 15 patents)


Core Competencies:
BCL6 Inhibitors
Lysyl Oxidase Inhibitors
Coumarin Derivatives
DNA Damage Repair Inhibitors
Pyrazole Derivatives
X-ray Micro-beam Production
Diffusion-weighted Magnetic Resonance Imaging
Prognostic Methods
Therapeutic Compositions
Pharmaceutical Combinations
Ataxia-Telangiectasia Mutated Inhibitors
Oligonucleotide Arrays

51 patents:

1. 12486285 - BCL6 inhibitors (2025-12-02),
2. 12421556 - Materials and methods for stratifying and treating cancers (2025-09-23),
3. 12390465 - Coumarin derivative for therapy or prophylaxis of a cell proliferative disorder (2025-08-19),
4. 12280050 - Therapeutic compositions, combinations, and methods of use (2025-04-21),
5. 12233060 - Inhibitors of Ataxia-Telangiectasia Mutated and Rad3-related protein kinase (ATR) for use in methods of treating cancer (2025-02-25),
6. 12189010 - Diffusion-weighted magnetic resonance imaging (2025-01-07),
7. 12060360 - Lysyl oxidase inhibitors (2024-08-13),
8. 12024506 - Compounds (2024-07-02),
9. 12018029 - Hexahydropyrrolo[3,4-c]pyrrole derivatives useful as LOX inhibitors (2024-06-25),
10. 11970469 - Compounds useful in the treatment of disorders associated with mutant RAS (2024-04-30),
11. 11788148 - Prognostic and treatment response predictive method (2023-10-17),
12. 11608330 - Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer (2023-03-21),
13. 11594394 - X-ray micro-beam production and high brilliance x-ray production (2023-02-28),
14. 11517573 - Therapeutic compositions, combinations, and methods of use (2022-12-06),
15. 11512095 - BCL6 inhibitors (2022-11-29),
The Institute of Cancer Research, London, is one of the world's most influential cancer research organizations. It is dedicated to understanding the fundamental biology of cancer and finding new ways to treat, diagnose, and prevent the disease. The Institute collaborates with leading academic, industry, and healthcare partners worldwide to accelerate discoveries and ensure their translation into patients. With its partner hospital, The Royal Marsden NHS Foundation Trust, it forms the largest comprehensive cancer center in Europe.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

...
51 Patents

#66 in London

#334 in United Kingdom

#13,365 in the World

...
London, United Kingdom

The Institute of Cancer Research: Royal Cancer Hospital

Forward Citations = 174

214 inventors:

goldMedal Dan Niculescu-Duvaz (11 out of 26 patents)

silverMedal Caroline Joy Springer (11 out of 41 patents)

bronzeMedal Robert George Boyle (9 out of 23 patents)

4.  Richard Marais (9 out of 26 patents)

5.  Ian James Collins (9 out of 41 patents)

Please report any incorrect information to support@idiyas.com
Loading…